Theravance Biopharma, Inc. (TBPH)
Sep 23, 2026 - TBPH was delisted (reason: acquired by ZYME)
17.03
0.00 (0.00%)
Inactive · Last trade price on Sep 23, 2026
Theravance Biopharma Market Cap
Theravance Biopharma is not actively traded anymore. When Theravance Biopharma last traded, it had a market cap or net worth of $884.18 million.
Market Cap
884.18M
Enterprise Value
535.09M
1-Year Change
24.78%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from $740.70M to $884.18M, an increase of 19.37%. That is a compound annual growth rate of 1.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 884.20M | -6.74% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
| May 16, 2014 | 740.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding